Sign Up Today and Learn More About Counsyl Stock
Invest in or calculate the value of your shares in Counsyl or other pre-IPO companies through EquityZen's platform.
About Counsyl Stock
Founded
2008
Headquarters
South San Francisco, CA, US
Total Funding
102M
Industries
Software, Data and Analytics, Artificial Intelligence
Counsyl is a genetic screening and counseling services company. The company provides women and their families with actionable information to guide health decisions. Counsyl operates a clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to integrate into clinic workflows and patients’ lives. Their genetic screens provide actionable information to patients and their healthcare providers through process that facilitates clinical decision-making.
The company launched their first commercial screen in 2009, and in January 2018, reached a milestone of having delivered one million patient results.
How Counsyl Works
Source: Counsyl
Counsyl Press Mentions
Stay in the know about the latest news on Counsyl
Counsyl's 1M Genetic Screens Underscore Popularity of Testing
hcanews.com • Feb 02, 2018
Counsyl Surpasses One Million Genetic Screens
Business Wire (press release) • Jan 30, 2018
Counsyl Secures Approval From New York State Department of ...
Business Wire (press release) • Jan 16, 2018
Counsyl Appoints Ann Rhoads to Board of Directors | Business Wire
Business Wire (press release) • Jan 04, 2018
Counsyl Appoints Pamela Sedmak to Board of Directors
Business Wire (press release) • Dec 14, 2017
Investors in Counsyl
Discover investors in Counsyl stock and explore their portfolio companies
Counsyl Management
Leadership team at Counsyl
Co-Founder & Chief Executive Officer
Ramji Srinivasan
Co-Founder & Chief Science Officer
Eric Evans
Join now and verify your accreditation status to gain access to:
- Counsyl current valuation
- Counsyl stock price
- Available deals in Counsyl and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Counsyl stock?
Accredited investors can buy pre-IPO stock in companies like Counsyl through EquityZen funds. These investments are made available by existing Counsyl shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Counsyl stock?
Shareholders can sell their Counsyl stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
